A Comparison of Respiratory Syncytial Viral Prophylaxis in Multiple Births versus Singletons in the Canadian Registry of Palivizumab

Autor: Abby Li, Caress Investigators, Doyoung Kim, Krista L. Lanctôt, Ian Mitchell, Bosco Paes

Publikováno v: American Journal of Perinatology. 38:e129-e136

Objective The aim of this study is to compare respiratory illness-related hospitalization (RIH) and respiratory syncytial virus (RSV)-related hospitalization (RSVH) in multiple births versus singletons, who received palivizumab during the RSV season

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fbd25831ffdb56c9797907d0af1df13c
https://doi.org/10.1055/s-0040-1708804

Respiratory Syncytial Virus Prophylaxis in Neurologic and Muscular Disorders in the Canadian Respiratory Syncytial Virus Evaluation Study of Palivizumab

Autor: Abby Li, Caress Investigators, Bosco Paes, Krista L. Lanctôt, Ian Mitchell, Mahwesh Saleem, Daniel Y. Wang

Publikováno v: Pediatric Infectious Disease Journal. 38:775-780

This study aimed to examine the risk of respiratory-related hospitalization in children with neurologic and muscular disorders (NMDs) who received respiratory syncytial virus (RSV) prophylaxis in the Canadian RSV Evaluation Study of Palivizumab.Canad

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a8ce3715907223c466e219c12a149886
https://doi.org/10.1097/inf.0000000000002297

Respiratory Syncytial Virus Prophylaxis in Immunocompromised Children: Outcomes From the Canadian RSV Evaluation Study of Palivizumab Registry Over Twelve Seasons (2005-2017).

Autor: Paes BA; From the Department of Pediatrics, McMaster University, Hamilton, Ontario, Canada., Saleem M; Medical Outcomes and Research in Economics (MORE) Research Group, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, Ontario, Canada., Li A; Medical Outcomes and Research in Economics (MORE) Research Group, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, Ontario, Canada., Lanctôt KL; Medical Outcomes and Research in Economics (MORE) Research Group, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, Ontario, Canada., Mitchell I; Department of Pediatrics, University of Calgary, Calgary, Alberta, Canada.

Publikováno v: The Pediatric infectious disease journal [Pediatr Infect Dis J] 2020 Jun; Vol. 39 (6), pp. 539-545.

Respiratory Syncytial Virus Immunoprophylaxis with Palivizumab: 12-Year Observational Study of Usage and Outcomes in Canada.

Autor: Mitchell I; Department of Paediatrics, University of Calgary, Alberta Children's Hospital, Calgary, Alberta, Canada., Li A; Medical Outcomes and Research in Economics, Sunnybrook Health Sciences, Centre, Toronto, Ontario, Canada., Bjornson CL; Department of Paediatrics, University of Calgary, Alberta Children's Hospital, Calgary, Alberta, Canada., Lanctot KL; Medical Outcomes and Research in Economics, Sunnybrook Health Sciences, Centre, Toronto, Ontario, Canada., Paes BA; Department of Pediatrics, McMaster University, Hamilton, Ontario, Canada.

Publikováno v: American journal of perinatology [Am J Perinatol] 2022 Nov; Vol. 39 (15), pp. 1668-1677. Date of Electronic Publication: 2021 Mar 03.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.